21 results
424B3
IKT
Inhibikase Therapeutics Inc
4 Apr 23
Prospectus supplement
4:57pm
;
the proximity of patients to a trial site;
the COVID-19 pandemic;
the design of a trial;
our ability to recruit clinical trial investigators … and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing and other
POS AM
IKT
Inhibikase Therapeutics Inc
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
primary endpoints;
the proximity of patients to a trial site;
the COVID-19 pandemic;
the design of a trial;
our ability to recruit clinical trial … consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish
424B4
yusxmrojgnrpc5gb
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
n9deb9oz8jn e6s9
2 Jun 21
Draft registration statement
12:00am
10-K
6maf6407mc
31 Mar 21
Annual report
2:14pm
424B4
4a9nc xv2zd
28 Dec 20
Prospectus supplement with pricing info
6:04am
S-1
gix3r3 slf
23 Jul 20
IPO registration
12:28pm
S-1
EX-10.5
3icly 586znj5fr
23 Jul 20
IPO registration
12:28pm